Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer

Urology

Volumn 53, Issue 3, 1999, Pages 553-556

  Kubricht, William S ^a   Kattan, Michael W ^a   Sartor, Oliver ^a,b   Eastham, James A ^a  

^a OVERTON BROOKS VA MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CLINICAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE; RISK FACTOR; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BIOPSY; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 0033105937     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00548-2     Document Type: Article

References (16)

1. Parker S.L., Tone T., Bolden S., et al. Cancer statistics 1997. CA Cancer J Clin. 47:1997;5-27.
2. Boring C.C., Squires T.S., Heath C.W. Jr. Cancer statistics for African-Americans. CA Cancer J Clin. 42:1992;7-17.
3. Morton R.A. Jr. Racial differences in adenocarcinoma of the prostate in North American men. Urology. 44:1994;637-645.
4. Powell I.J. Prostate cancer and African-American men. Oncology. 11:1997;599-601.
5. Dale W., Vijayakumar S., Lawlor E., et al. Prostate cancer, race and socioeconomic status inadequate adjustment for social factors in assessing racial differences . Prostate. 29:1996;271-281.
6. Morgan T.O., Jacobsen S.J., McCarthy W.F., et al. Age-specific reference ranges for serum prostate-specific antigen in black men. N Engl J Med. 335:1996;304-310.
7. Eastham J.A., May R.A., Whatley T., et al. Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer. J Natl Cancer Inst. 90:1998;756-760.
8. DeAntoni E.P., Crawford E.D., Oesterling J.E., et al. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology. 48:1996;234-239.
9. Moul J.W., Sesterham I.A., Conelly R.R., et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 274:1995;1277-1281.
10. Vijayakumar S., Karrison J., Weichselbaun R.R., et al. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol Biomarkers Prev. 1:1992;541-545.
11. Harrell FE: Design: S-Plus function for biostatistical/epidemiologic modeling, testing, estimation, validation, graphics, prediction, and typesetting by storing enhanced model design attributes in the fit. 1998: Programs available from http://lib.stat.cmu.edu.
12. Oesterling J.E., Kumamoto Y., Tsukamoto T., et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men lower values than for similarly aged white men . Br J Urol. 75:1995;347-353.
13. Partin A.W., Carter H.B., Chan D.W., et al. Prostate specific antigen in the staging of localized prostate cancer influence of tumor differentiation, tumor volume and benign hyperplasia . J Urol. 143:1990;747-752.
14. Crawford E.D., DeAntoni E.P. PSA as a screening test for prostate cancer. Urol Clin North Am. 20:1993;637-646.
15. Benson M.C., Whang I.S., Olsson C.A., et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate-specific antigen. J Urol. 147:1992;817-821.
16. Presti J.C. Jr, Hovey R., Bhargava V., et al. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate ethnic variations . J Urol. 157:1997;907-912.